Latest News

Image description

BD to acquire Bard for $24B

The combination will “create a highly differentiated medical technology company uniquely positioned to improve both the process of care and the treatment of disease for patients and healthcare providers," stated BD.

Image description

CVS Health’s Sansone discusses partnership, transformation at recent Elevation Forum

“Only 8% of leaders are good at both strategy and execution, which means you must discover the sweet spot of knowing yourself, your competitors and your terrain.  The very best win with ‘ideas’ and are obsessed with their front-line customer relationships.”  That was one of the key messages conveyed by Elevation Forum founder and Mack Elevation leader Dan Mack at the most recent Elevation Form held in Scottsdale, Ariz., on Friday.

Image description

FDA approves Remicade biosimilar

Renflexis, marketed by Merck and developed by South Korea's Samsung Bioepis, is the second FDA-approved biosimilar to Johnson & Johnson’s Remicade.

Image description

Target’s innovation head to depart

Casey Carl, who departs his position as chief innovation and strategy officer, effective May 5, joined the company in 1997, and has held various positions in merchandising, negotiations, operations and digital. 

Image description

Mylan launches schizophrenia generic

Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg are the generic version of the reference listed drug, Trilafon Tablets 2 mg, 4 mg, 8 mg and 16 mg, originally marketed by Schering.